CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
35 hedge funds and large institutions have $1.56M invested in Carisma Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
35
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$59.1K | |
| 2 | +$29.6K | |
| 3 | +$19.6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.46K |
| 5 |
Goldman Sachs
New York
|
+$5.1K |
Top Sellers
| 1 | -$410K | |
| 2 | -$62K | |
| 3 | -$27.4K | |
| 4 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$6.88K |
| 5 |
LPL Financial
San Diego,
California
|
-$6.48K |
